HudBay Minerals seeks to block Augusta’s poison pill


HudBay Minerals (HBM) attempts to strike down Augusta Resources' (AZC) shareholder rights plan, asking British Columbia's securities regulator to cease trade AZC’s poison pill so that its hostile takeover bid can proceed as planned.

CEO David Garofalo says AZC's board has had more than enough time to study its alternatives after receiving HBM's hostile takeover bid.

HBM is offering 0.315 of its shares for each AZC share, which gives the bid a value of slightly more than $400M, but AZC shares have traded well above the offer price as investors expect a higher bid.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs